Breckenridge Pharmaceutical is recalling one lot of its blood pressure medications after detecting potential metal contamination. The company says the contamination can cause cuts in areas such as the mouth, throat and other parts of the digestive tract.

Outlet coverage focuses on the recall’s scope and the drug affected. The Washington Times highlights the health risk of internal cuts stemming from metal contamination. Quartz emphasizes the specific product and dosage, describing the recalled item as 60 mg propranolol extended-release capsules and noting it was distributed to wholesalers and pharmacies nationwide. Both accounts refer to the same company recall and the same underlying contamination concern.